- Advertisement -

A breakthrough breath analyzer detects silent blood clots

  • Scientists can now detect early signs of deadly blood clots in diseases like COVID-19 and heart disease by analyzing biomolecules found in the breath.
  • Researchers have developed a technique to track the formation of small blood clots by analyzing exhaled air, which can be an early sign of many diseases.
  • Immunothrombosis, driven by inflammation, involves the formation of minuscule clots throughout small blood vessels and can contribute to complications in various conditions.
  • The research team developed a non-invasive technique that analyzes exhaled gases to detect thrombin, an enzyme key to blood clot formation, as an indicator of systemic immunothrombosis.
  • A breakthrough in detecting silent blood clots

    Scientists have made a breakthrough in detecting silent blood clots by analyzing biomolecules found in the breath. By tracking the formation of small blood clots through exhaled air, researchers can identify early signs of diseases like COVID-19 and heart disease. Immunothrombosis, driven by inflammation, can lead to complications in various conditions. The research team developed a non-invasive technique that analyzes exhaled gases to detect thrombin, a key enzyme in blood clot formation, as an indicator of systemic immunothrombosis. This breakthrough could revolutionize early detection and improve patient outcomes.

    The importance of detecting silent blood clots

    Early detection of silent blood clots can be crucial in preventing complications and improving patient outcomes. Small blood clots that worsen clinical symptoms are often not easily detectable, making it challenging to intervene early. By analyzing biomolecules in the breath, scientists can now identify the formation of these tiny clots, providing a non-invasive and early detection method. This breakthrough technique has the potential to save lives and improve the management of diseases like COVID-19, heart disease, sepsis, and more.

    - Advertisement -

    Immunothrombosis, characterized by the formation of minuscule clots throughout small blood vessels, is driven by inflammation. It can significantly contribute to complications in people with various conditions, including sepsis, heart disease, and diabetes. Detecting and monitoring the activity of thrombin, a key enzyme in blood clot formation, is essential in understanding and managing immunothrombosis. The non-invasive breath analyzer developed by researchers offers a promising solution to track thrombin activity and detect early signs of silent blood clots, ultimately leading to better patient care.

    Source Credit

    Disclaimer: We want to be clear that the information on Bollyinside.com, including news, articles, reviews, and opinions, is intended for reading and knowledge purposes only. While we strive to provide accurate and up-to-date information, opinion and news, we cannot guarantee the completeness, accuracy, reliability, suitability, or availability of any information. Read more

    Source link